Before the approval of lurbinectedin, just 1 drug—topotecan—had approval for this indication, leaving these patients with few treatment options after progressing on their initial therapy.
Small Cell Lung Cancer Guideline Updates 2020 | articles
In June, lurbinectedin became just the second approved treatment for patients whose metastatic small cell lung cancer (SCLC) has progressed on or after platinum-based chemotherapy, joining topotecan.
Advertisement
Advertisement
Trending on AJMC
1
Guideline-Directed Medical Therapies in Heart Failure
2
Responsible Use of Energy-Based Treatments on Skin of Color: Eliot F. Battle, MD
3
Coordinating Medications for Women With Arrhythmia: Lindsey Valenzuela, PharmD
4
Collaboration in Heart Failure Treatment
5
